La cadena de opciones muestra datos clave de las opciones de acciones de Plus Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Plus Therapeutics..

Plus Therapeutics (NASDAQ:PSTV) Bolsa, Cadena de Opciones

Plus Therapeutics

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Plus Therapeutics Inc

POSTAL SVGS CHINA UNS/ADR by Postal Svgs Bk of China Ltd.

Postal Savings Bank Of China Co Ltd

WIIM

New York Times shares are trading lower after the company reported Q4 financial results and missed its revenue estimate.

Baird analyst Jeffrey Meuler maintains Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) with a Neutral and lowers the price target from $1975 to $1775.

News

Price Target

Analyst Ratings

FICO

Baird Maintains Neutral on Fair Isaac, Lowers Price Target to $1775

Shares of Brazil based aircraft manufacturer Embraer SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERJ#NYSE">ERJ</a>) are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">higher on Wednesday</a>.
Embraer Executive Jets, a division of Embraer, has reached a <a target="_blank" href="https://www.benzinga.com//node/43492884" rel="noreferrer noopener">major purchase agreement with </a><a target="_blank" href="https://www.benzinga.com//node/43492884" rel="noreferrer noopener">Flexjet</a><a target="_blank" href="https://www.benzinga.com//node/43492884" rel="noreferrer noopener">.</a>
The new agreement is worth up to $7 billion, encompassing a firm order for 182 aircraft, along with 30 options, as well as an upgraded package of services and support.
The deal includes a range of Embraer business jets, including the Praetor 600, Praetor 500, and Phenom 300E models.
Valued at up to $7 billion based on current list prices, this is Flexjet&#8217;s largest order in its 30-year history, as well as Embraer&#8217;s biggest firm order for executive aircraft.
The partnership between Embraer and Flexjet began in 2003 with the launch of the legacy Executive jet. Flexjet&#8217;s newest acquisition will further enhance its growing global fleet.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43429620/triumph-group-reaches-3b-acquisition-deal-with-private-equity-investors" rel="noreferrer noopener">Triumph Group Agrees To Go Private In $3 Billion Acquisition Deal</a>
&#8220;Since 2003, we have accepted delivery of more than 150 Embraer aircraft,&#8221; said&nbsp;Flexjet CEO Michael Silvestro.
&#8220;Both the Praetor 500 and Praetor 600 are high performers in the Flexjet fleet. Praetor 600 was so well accepted in&nbsp;Europe, we opted to include it in our North American fleet in 2023, extending our Embraer fleet across two continents.&#8221;
Embraer delivered 75 aircraft in the fourth quarter of FY24, a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n43036046/embraer-reached-75-deliveries-in-the-last-quarter-of-2024-for-a-total-of-206-new-aircraft-in-the-y" rel="noreferrer noopener">27% increase from the third quarter</a> of FY24. For the full year, deliveries increased 14% to 206 aircraft.
Price Action: ERJ shares are trading higher by 11.8% at $44.55 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/02/43429256/jeep-maker-stellantis-unveils-organizational-overhaul-stock-dips" target="_blank" rel="noreferrer noopener">Jeep Maker Stellantis Unveils Organizational Overhaul</a></li>
</ul>
Image via Shutterstock.

Equities

Contracts

Movers

Trading Ideas

General

Embraer-Empresa Brasileira De Aeronautica

Embraer Lands Record $7 Billion Flexjet Order, Stock Jumps

Tempur Sealy International To Change Name To Somnigroup International

Stephens &amp; Co. analyst Mike Scialla maintains Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) with a Overweight and lowers the price target from $21 to $20.

TALO

Stephens & Co. Maintains Overweight on Talos Energy, Lowers Price Target to $20

Baird analyst Michael Halloran maintains Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) with a Outperform and raises the price target from $139 to $148.

Baird Maintains Outperform on Xylem, Raises Price Target to $148

Stephens &amp; Co. analyst Andrew Terrell maintains RBB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBB#NASDAQ">RBB</a>) with a Equal-Weight and lowers the price target from $25 to $23.

Stephens & Co. Maintains Equal-Weight on RBB Bancorp, Lowers Price Target to $23

Baird analyst Michael Halloran maintains Pentair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) with a Neutral and raises the price target from $106 to $114.

Baird Maintains Neutral on Pentair, Raises Price Target to $114

Watching GeneDx Holdings Corp. Shares After Grizzly Reports Issues Bearish Report On Stock

Macro Economic Events

Econ #s

Economics

S&P Global Composite PMI For Jan 52.7 Vs 52.4 Est.; 55.4 Prior

Stephens &amp; Co. analyst Kyle Joseph maintains Enova International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENVA#NYSE">ENVA</a>) with a Overweight and raises the price target from $115 to $136.

ENVA

Stephens & Co. Maintains Overweight on Enova International, Raises Price Target to $136

Financial giants have made a conspicuous bearish move on Tesla. Our analysis of options history for Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) revealed 23 unusual trades.
Delving into the details, we found 26% of traders were bullish, while 65% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $917,359, and 12 were calls, valued at $475,981.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $375.0 to $400.0 for Tesla during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Tesla options trades today is 9884.45 with a total volume of 3,034.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Tesla's big money trades within a strike price range of $375.0 to $400.0 over the last 30 days.
<h3>Tesla 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738766774_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$18.5</td>
<td>$18.2</td>
<td>$18.5</td>
<td>$400.00</td>
<td>$370.0K</td>
<td>6.5K</td>
<td align="right">46</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$8.65</td>
<td>$8.5</td>
<td>$8.62</td>
<td>$385.00</td>
<td>$97.4K</td>
<td>5.9K</td>
<td align="right">468</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$8.25</td>
<td>$8.05</td>
<td>$8.1</td>
<td>$385.00</td>
<td>$90.5K</td>
<td>5.9K</td>
<td align="right">468</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$15.05</td>
<td>$14.65</td>
<td>$14.9</td>
<td>$375.00</td>
<td>$83.4K</td>
<td>2.9K</td>
<td align="right">101</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$7.25</td>
<td>$7.15</td>
<td>$7.18</td>
<td>$387.50</td>
<td>$71.8K</td>
<td>2.8K</td>
<td align="right">272</td>
</tr>
</tbody>
</table>

<h3>About Tesla</h3>
Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.
After a thorough review of the options trading surrounding Tesla, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Tesla Standing Right Now?</h3>
<ul>
<li>With a volume of 2,125,098, the price of TSLA is down -1.34% at $386.94. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 76 days.</li>
</ul>
<h3>Professional Analyst Ratings for Tesla</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $457.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Neutral with a price target of $365. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Tesla, which currently sits at a price target of $430. 
&#x2A; Maintaining their stance, an analyst from Wedbush continues to hold a Outperform rating for Tesla, targeting a price of $550. 
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $440. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Tesla, targeting a price of $500. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Tesla options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

TSLA

Tesla Unusual Options Activity For February 05

S&P Global Services PMI For Jan 52.9 Vs 52.8 Est.; 56.8 Prior

High-rolling investors have positioned themselves bearish on Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in AVGO often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for Broadcom. This is not a typical pattern.
The sentiment among these major traders is split, with 12% bullish and 50% bearish. Among all the options we identified, there was one put, amounting to $51,830, and 7 calls, totaling $478,206.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $190.0 to $235.0 for Broadcom over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Broadcom stands at 3190.8, with a total volume reaching 565.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Broadcom, situated within the strike price corridor from $190.0 to $235.0, throughout the last 30 days.
<h3>Broadcom Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738766769_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/14/25</td>
<td>$9.6</td>
<td>$9.05</td>
<td>$9.35</td>
<td>$230.00</td>
<td>$187.0K</td>
<td>1.8K</td>
<td align="right">1</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/07/25</td>
<td>$2.71</td>
<td>$2.69</td>
<td>$2.7</td>
<td>$235.00</td>
<td>$70.0K</td>
<td>7.4K</td>
<td align="right">340</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$11.4</td>
<td>$11.0</td>
<td>$11.4</td>
<td>$225.00</td>
<td>$57.0K</td>
<td>1.7K</td>
<td align="right">101</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$2.71</td>
<td>$2.64</td>
<td>$2.64</td>
<td>$235.00</td>
<td>$53.6K</td>
<td>7.4K</td>
<td align="right">340</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$7.1</td>
<td>$7.1</td>
<td>$7.1</td>
<td>$230.00</td>
<td>$51.8K</td>
<td>2.9K</td>
<td align="right">113</td>
</tr>
</tbody>
</table>

<h3>About Broadcom</h3>
Broadcom is the sixth-largest semiconductor company globally and has expanded into various software businesses, with over $30 billion in annual revenue. It sells 17 core semiconductor product lines across wireless, networking, broadband, storage, and industrial markets. It is primarily a fabless designer but holds some manufacturing in-house, like for its best-of-breed FBAR filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments.Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as Brocade, CA Technologies, and Symantec in software.
After a thorough review of the options trading surrounding Broadcom, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Broadcom</h3>
<ul>
<li>With a volume of 1,855,928, the price of AVGO is up 3.39% at $229.96. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 29 days.</li>
</ul>
<h3>Expert Opinions on Broadcom</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $255.33333333333334.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for Broadcom, targeting a price of $260. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Broadcom, which currently sits at a price target of $260. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Broadcom, which currently sits at a price target of $246. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Broadcom, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

AVGO

Broadcom's Options: A Look at What the Big Money is Thinking

Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) has outperformed the market over the past 5 years by 11.69% on an annualized basis producing an average annual return of 24.06%. Currently, Freeport-McMoRan has a market capitalization of $52.38 billion. 
Buying $100 In FCX: If an investor had bought $100 of FCX stock 5 years ago, it would be worth $299.47 today based on a price of $36.45 for FCX at the time of writing.
<h3>Freeport-McMoRan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738766757_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Freeport-McMoRan 5 Years Ago Would Be Worth Today

Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) shares are trading higher Wednesday. The stock spiked late Tuesday after Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) reported fourth-quarter results showing it expects to <a href="https://www.benzinga.com/25/02/43479274/alphabet-q4-earnings-highlights-ai-cloud-youtube-momentum-continues-capex-guidance-sends-shares-lower">increase AI spending in 2025</a>. 
What To Know: Google reported fourth-quarter financial results after the market close on Tuesday. The company said it expects $75 billion in capital expenditures in 2025 related to its AI buildout. Google reported $52.5 billion in capital expenditures in 2024 and analysts had been expecting the company to spend about $58 billion in 2025, per Reuters. 
There had been some concerns about AI spending leading up to earnings season after Chinese startup DeepSeek reportedly developed its open-source LLM in a couple of months at a much lower cost than competitors in the space. 
Broadcom shares jumped late Tuesday as Google&#8217;s capital expenditures forecast lowered concerns of an AI spending slowdown. Google is one of Broadcom&#8217;s largest AI chip customers. 
Check This Out: <a href="https://www.benzinga.com/markets/equities/25/02/43485518/google-ais-search-revenue-matches-traditional-ads-says-alphabet-but-there-is-rising-competition-from-openai-perplexity-deepseek">Google AI&#8217;s Search Revenue Matches Traditional Ads, Says Alphabet But There Is Rising Competition From OpenAI, Perplexity, DeepSeek</a>
Broadcom isn&#8217;t expected to report quarterly results again until early March. Analysts currently expect the company to report earnings of $1.49 per share and revenue of $14.63 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Last quarter, Broadcom reported mixed financial results. Chip revenue grew to a record $30.1 billion, driven by AI revenue of $12.2 billion, up 220% year over year. The company guided for first-quarter revenue of approximately $14.6 billion and adjusted EBITDA of approximately 66% of projected revenue.
"We see our opportunity over the next three years in AI as massive. Specific hyperscalers have begun their respective journeys to develop their own custom AI accelerators,&#8221; Broadcom CEO Hock Tan said on an earnings call in December.
AVGO Price Action: <a href="http://benzinga.com/quote/avgo">Broadcom shares</a> were up 3.26% at $229.52 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

GOOG

Broadcom Stock Is Rising Wednesday: What's Going On?

Kevin Hart and billionaire investor Mark Cuban have one major regret in common:&nbsp;
They both passed on the chance to invest in Uber (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NASDAQ">UBER</a>)&nbsp; when it was just getting started. And looking at Uber today, that decision still stings.
On an <a href="https://youtu.be/xvAQ9MWkomA?si=dCUwEHj6cdtNuwWY">episode</a> of Hart to Heart, Kevin Hart's talk show, the two shared how they let the opportunity slip away. Back then, the idea of strangers hopping into cars with other strangers seemed like a disaster waiting to happen. Hart even called it &#8220;Murderville,&#8221; thinking it was the dumbest idea he'd ever heard.&nbsp;
Cuban, on the other hand, was actually interested—but only if he could invest at a lower price. When his offer wasn't accepted, he walked away.
Don't Miss:
<ul>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a></li>
<li>Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a></li>
</ul>
Troy Carter, a former music manager turned tech investor, was the one who first pitched Uber to Hart. He told him, &#8220;There&#8217;s this thing, man. It&#8217;s called Uber. You got to invest in it.&#8221; But Hart just couldn't see the potential even after Carter further explained the concept: &#8220;There&#8217;s an app, and you say you need a ride, and whoever&#8217;s close to you, that is like one of the drivers under our app will come get you.&#8221; &#8220;Sounds like Murderville to me. This has to be the stupidest shit I ever heard,&#8221; he told Carter.
Fast forward to today, and Uber is a massive success. In the third quarter of 2024, the company <a href="https://www.benzinga.com/25/01/42812603/uber-cfo-highlights-undervalued-stock-while-accelerating-buyback-efforts-through-15-billion-asr-deal">reported $11.19 billion</a> in revenue, up 20% from 2023. Uber's Gross Bookings hit $40.97 billion, a 16% year-over-year jump, and ride-hailing bookings rose 17% to $21 billion.
Uber also <a href="https://www.benzinga.com/news/25/01/43127666/uber-eats-partners-with-home-depot-for-on-demand-deliveries">does more than simple rides</a> nowadays—it dominates food delivery through Uber Eats and has expanded into freight and logistics.&nbsp;
Trending: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
Hart and Cuban admit that turning down Uber was a tough lesson. &#8220;Don't feel bad,&#8221; Cuban told Hart, but Hart still thinks about it. &#8220;Until this f&#x2A;&#x2A;&#x2A;ing day,&#8221; he admitted, adding that he kind of avoids running into Carter because of it.
Of course, they're not the only ones who've let billion-dollar opportunities slip away. In 2000, Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) co-founder Reed Hastings offered to sell the company to Blockbuster for just $50 million. Blockbuster passed, failing to see the future of streaming. Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) also struggled early on, with many investors doubting that people would rent their homes to strangers. Today, Airbnb is valued at around $82 billion. In fact, here are <a href="https://www.benzinga.com/money/how-invest-airbnb">simple steps</a> on how you, too, can invest in this company.&nbsp;
The lesson? Some of the wildest ideas turn into industry giants. Even the best investors don't always get it right.
Disclaimer: Some elements of this story were previously reported by Benzinga and it has been updated.
Read Next:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

ABNB

NFLX

UBER

'Sounds Like Murderville'—Both Mark Cuban And Kevin Hart Passed On A Startup That Grew Into A Giant, Leaving Them Regretting It

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.08% to 44,590.52 while the NASDAQ fell 0.55% to 19,545.97. The S&amp;P 500 also fell, dropping, 0.17% to 6,027.54.
Check This Out: <a href="https://www.benzinga.com/25/02/43490310/top-2-health-care-stocks-that-may-crash-in-february">Top 2 Health Care Stocks That May Crash In February</a>
Leading and Lagging Sectors Utilities shares surged by 1.1% on Wednesday.
In trading on Wednesday, communication services shares fell by 2.6%.
Top Headline
The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) reported better-than-expected first-quarter financial results.
Walt Disney reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.45 per share. The company reported quarterly sales of $24.70 billion which beat the analyst consensus estimate of $24.62 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Oragenics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#NYSE">OGEN</a>) shares shot up 94% to $0.55.</li>
<li>Shares of Pasithea Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>)got a boost, surging 59% to $3.32 after a Safety Review Committee recommended proceeding to Cohort 5 in its Phase 1 trial of PAS-004 without modification.</li>
<li>Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares were also up, gaining 41% to $5.18 after the company reported a 37% YoY increase in third-quarter total net revenue.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Volcon Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares dropped 39% to $1.96 after the company announced the pricing of $12.0 million underwritten public offering.</li>
<li>Shares of FMC Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were down 36% to $34.70 following weak guidance.</li>
<li>Lottery.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) was down, falling 29% to $0.42. Lottery.com recently announced an international operations expansion by targeting Europe, Africa, and other emerging markets.</li>
</ul>
Commodities In commodity news, oil traded down 1.2% to $71.86 while gold traded up 0.5% at $2,889.50.
Silver traded down 0.4% to $32.880 on Wednesday, while copper rose 0.2% to $4.3620.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.2%, Germany's DAX 40 slipped 0.1% and France's CAC 40 fell 0.2%. Spain's IBEX 35 Index rose 1.2%, while London's FTSE 100 rose 0.2%.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 gaining 0.09%, China's Shanghai Composite Index falling 0.65%, Hong Kong's Hang Seng Index falling 0.93% and India's BSE Sensex falling 0.40%.
Economics
<ul>
<li>The U.S. trade deficit increased to $98.4 billion in December versus a revised $78.9 billion gap in the previous month and compared to market estimates of a $96.6 billion gap.</li>
<li>U.S. private businesses added 183,000 workers to their payrolls in January, compared to a revised 176,000 gain in December and above expectations of 150,000.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43491430/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>

Earnings

Eurozone

Commodities

Intraday Update

KTTA

LTRY

OGEN

VLCN

US Stocks Mixed; Walt Disney Posts Upbeat Earnings

Jefferies analyst Omar Nokta maintains Costamare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMRE#NYSE">CMRE</a>) with a Hold and maintains $13 price target.

CMRE

Jefferies Maintains Hold on Costamare, Maintains $13 Price Target

Toyota Motor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) has unveiled a major partnership with the Shanghai municipal government to <a href="https://global.toyota/en/newsroom/corporate/42193101.html">support carbon neutrality efforts</a>. 
This collaboration will concentrate on key areas such as hydrogen energy, self-driving technology and battery recycling.
As part of the agreement, the company will set up a fully-owned subsidiary in Jinshan District, Shanghai, to address the increasing demand for new energy vehicles in China.
Toyota&#8217;s upcoming subsidiary will be central to manufacturing battery electric vehicles (BEVs) and batteries. 
The company plans to introduce a new Lexus BEV model, with production slated for 2027. At the outset, the facility is expected to produce 100,000 units annually, while also creating approximately 1,000 jobs during its initial phase of operation.
Also Read: <a href="https://www.benzinga.com/news/management/25/02/43429256/jeep-maker-stellantis-unveils-organizational-overhaul-stock-dips">Jeep Maker Stellantis Unveils Organizational Overhaul</a>
Toyota sold over a million electrified vehicles in the U.S., including nearly 900,000 Toyota brand vehicles and over 100,000 Lexus brand vehicles, marking a <a href="https://www.benzinga.com/tech/25/01/42809131/toyota-overtakes-ford-gm-in-ev-sales-in-us-thanks-to-its-hybrid-vehicle-lineup">growth of over 50% year-on-year</a>.
The company retained its position as the world's best-selling automaker in 2024 with 10.8 million sales, out of which <a href="https://www.benzinga.com/tech/25/01/43380849/toyota-retains-top-selling-automaker-position-while-continuing-to-trail-tesla-byd-in-ev-sales">4.5 million were electrified vehicles</a>.
Electrified vehicles encompass a range of types, including hybrid, plug-in hybrid, battery electric, mild hybrid and fuel-cell electric vehicles.
The company raised its full-year operating income forecast by 400 billion yen ($2.62 billion), bringing the total to 4,700 billion yen for the fiscal year ending in March 2025.
Toyota&#8217;s latest initiative supports China&#8217;s ambition to reach net-zero emissions by 2060. Through established collaborations with major local players like China FAW Group Co. and Guangzhou Automobile Group Co., Toyota aims to enhance its footprint, offering environmentally friendly solutions while playing a key role in China&#8217;s shift toward sustainability.
Price Action: TM shares are trading higher by 2.63% at $192.50 in premarket at the last check Wednesday.
Read Next: <a href="https://www.benzinga.com/25/02/43463646/alcohol-giant-diageo-suspends-guidance-as-trumps-tariff-looms">Alcohol Giant Diageo Suspends Medium-Term Guidance As Trump&#8217;s Tariff Looms</a>
Photo: Shutterstock

Toyota To Open New EV Production Facility In Shanghai

Plus Therapeutics GAAP EPS of -$0.37 beats by $0.19, revenue of $1.45M beats by $0.31M

Plus Therapeutics ( ($PSTV) ) has released its Q3 earnings. Here is a breakdown of the information Plus Therapeutics presented to its investors. Pl...

Plus Therapeutics Advances Radiotherapeutics in Q3 2024

Analyst Sean Lee CFA from H.C. Wainwright maintained a Buy rating on Plus Therapeutics (PSTV – Research Report) and keeping the price target at $8....

Plus Therapeutics: Promising Growth and Stability Backed by Financial Strength and Clinical Innovations

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Plus Therapeutics (PSTV – Research Report). The associated price target i...

Positive Outlook for Plus Therapeutics: Strong Financial Support and Clinical Advancements Justify Buy Rating

Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript

CNSide Diagnostics, a wholly owned subsidiary of Plus Therapeutics (PSTV), will present data demonstrating the utility of the CNSide CSF Assay Plat...

Plus Therapeutics subsidiary to present data on CNSide CSF Assay Platform

CNSide Diagnostics will present data from the FORESEE trial showcasing the CNSide CSF Assay Platform's utility in diagnosing and guiding clinical d...

Plus Therapeutics to present FORESEE clinical trial summary

Plus Therapeutics (PSTV) presented data updating the progress of its ReSPECT-LM Phase 1 clinical trial of Rhenium Obisbemeda in leptomeningeal dise...

Plus Therapeutics presents updated progress from its ReSPECT-LM Phase 1 trial

Plus Therapeutics (PSTV) announced the renewal of its Master Services Agreement, MSA, with Telix IsoTherapeutics Group. This MSA secures a reliable...

Plus Therapeutics expands strategic agreement with Telix IsoTherapeutics

Plus Therapeutics presented data on ReSPECT-LM Phase 1 trial

PSTV

Screenshot 2024-03-29 at 1.10.09 AM

Biotech

This Biotech Is Creating Targeted Radiotherapuetics For Some Of The Deadliest Cancers

Press Releases

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas

Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases

Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases

Health Care

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference

Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply

Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

Comments

Plus Therapeutics

Plus Therapeutics (PSTV) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL